Clinically significant differences: what to choose?

Johnnatas Mikael LOPES; Achiles de Souza ANDRADE; Bruno da Silva BRITO; Isabella Guilherme de Carvalho COSTA

doi:10.1590/0004-282X20200011

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2020; 78(06): 387-388
DOI: 10.1590/0004-282X20200011

Letter

Clinically significant differences: what to choose?

Diferenças clinicamente significativas: o que escolher?

Authors

Johnnatas Mikael LOPES

¹Universidade Federal do Vale do São Francisco, Colegiado de Medicina, Paulo Afonso BA, Brazil.
Achiles de Souza ANDRADE

²Universidade Federal da Paraíba, Departamento de Medicina, João Pessoa PB, Brazil.
Bruno da Silva BRITO

³Hospital Metropolitano Dom José Maria Pires, João Pessoa PB, Brazil.
Isabella Guilherme de Carvalho COSTA

²Universidade Federal da Paraíba, Departamento de Medicina, João Pessoa PB, Brazil.

Abstract

Full Text

References

References
1 Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2016 Jun;47(6):e98-e169. https://doi.org/10.1161/STR.20200011202000110098
2 McGlothlin AE, Lewis RJ. Minimal clinically important difference: Defining what really matters to patients. JAMA. 2014 Oct;312(13):1342-3. https://doi.org/10.1001/jama.2014.13128 .
3 Cook CE. Clinimetrics corner: The Minimal Clinically Important Change Score (MCID): a necessary pretense. J Man Manip Ther. 2008;16(4):82E-83E. https://doi.org/10.1179/jmt.2008.16.4.82E
4 Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008 Feb;61(2):102-9. https://doi.org/10.1016/j.jclinepi.2007.03.012
5 Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front Psychol. 2013 Nov;4:863. https://doi.org/10.3389/fpsyg.2013.00863
6 Johnston BC, Ebrahim S, Carrasco-Labra A, Furukawa TA, Patrick DL, Crawford MW, et al. Minimally important difference estimates and methods: A protocol. BMJ Open. 2015;5(10):1-7. https://doi.org/10.1136/bmjopen-2015-007953
7 Ögün MN, Kurul R, Yaşar MF, Turkoglu SA, Avci Ş, Yildiz N. Effect of leap motion-based 3D immersive virtual reality usage on upper extremity function in ischemic stroke patients. Arq Neuropsiquiatr. 2019 Oct;77(10):681-8. https://doi.org/10.1590/0004-282X20190129
8 Beninato M, Gill-Body KM, Salles S, Stark PC, Black-Schaffer RM, Stein J. Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil. 2006 Jan;87(1):32-9. https://doi.org/10.1016/j.apmr.2005.08.130
9 Langhorne P, Sandercock P, Prasad K. Evidence-based practice for stroke. Lancet Neurol Lancet Neurol. 2009 Apr;8(4):308-9. https://doi.org/10.1016/S1474-4422(09)70060-2